Division of Endocrinology, Metabolism, and Lipid Research, Washington University, St. Louis, Missouri 63110, USA.
J Biol Chem. 2012 Nov 9;287(46):38482-94. doi: 10.1074/jbc.M112.386912. Epub 2012 Sep 24.
Cardiovascular disease is the leading cause of morbidity/mortality in patients with type 2 diabetes mellitus (T2DM), but there is a lack of knowledge about the mechanism(s) of increased atherosclerosis in these patients. In patients with T2DM, the prevalence of 25-hydroxy vitamin D (25(OH)D) deficiency is almost twice that for nondiabetics and doubles the relative risk of developing cardiovascular disease compared with diabetic patients with normal 25(OH)D. We tested the hypothesis that monocytes from vitamin D-deficient subjects will have a proatherogenic phenotype compared with vitamin D-sufficient subjects in 43 patients with T2DM. Serum 25(OH)D level inversely correlated with monocyte adhesion to endothelial cells even after adjustment for demographic and comorbidity characteristics. Vitamin D-sufficient patients (≥30 ng/ml 25(OH)D) had lower monocyte endoplasmic reticulum (ER) stress, a predominance of M1 over M2 macrophage membrane receptors, and decreased mRNA expression of monocyte adhesion molecules PSGL-1, β(1)-integrin, and β(2)-integrin compared with patients with 25(OH)D levels of <30 ng/ml. In vitamin D-deficient macrophages, activation of ER stress increased adhesion and adhesion molecule expression and induced an M2-predominant phenotype. Moreover, adding 1,25(OH)(2)D(3) to vitamin D-deficient macrophages shifted their phenotype toward an M1-predominant phenotype with suppressed adhesion. Conversely, deletion of the vitamin D receptor in macrophages from diabetic patients activated ER stress, accelerated adhesion, and increased adhesion molecule expression. The absence of ER stress protein CCAAT enhancer-binding protein homologous protein suppressed monocyte adhesion, adhesion molecule expression, and the M2-predominant phenotype induced by vitamin D deficiency. Thus, vitamin D is a natural ER stress reliever that induced an antiatherogenic monocyte/macrophage phenotype.
心血管疾病是 2 型糖尿病(T2DM)患者发病率和死亡率的主要原因,但人们对这些患者动脉粥样硬化增加的机制知之甚少。在 T2DM 患者中,25-羟维生素 D(25(OH)D)缺乏的患病率几乎是无糖尿病患者的两倍,与 25(OH)D 正常的糖尿病患者相比,发生心血管疾病的相对风险增加一倍。我们在 43 例 T2DM 患者中检验了这样一个假设,即与 25(OH)D 充足的受试者相比,维生素 D 缺乏的受试者的单核细胞将具有促动脉粥样硬化表型。血清 25(OH)D 水平与单核细胞黏附内皮细胞呈负相关,即使在调整人口统计学和合并症特征后也是如此。与 25(OH)D 水平<30ng/ml 的患者相比,维生素 D 充足的患者(≥30ng/ml 25(OH)D)的单核细胞内质网(ER)应激较低,M1 型巨噬细胞膜受体占优势,单核细胞黏附分子 PSGL-1、β(1)-整合素和β(2)-整合素的 mRNA 表达降低。在维生素 D 缺乏的巨噬细胞中,ER 应激的激活增加了黏附及黏附分子的表达,并诱导了 M2 型占优势的表型。此外,向维生素 D 缺乏的巨噬细胞中添加 1,25(OH)(2)D(3)可将其表型转变为 M1 型占优势的表型,同时抑制黏附。相反,从糖尿病患者的巨噬细胞中删除维生素 D 受体激活了 ER 应激,加速了黏附,并增加了黏附分子的表达。缺乏 ER 应激蛋白 CCAAT 增强子结合蛋白同源蛋白抑制了单核细胞黏附、黏附分子的表达以及维生素 D 缺乏诱导的 M2 型表型。因此,维生素 D 是一种天然的 ER 应激缓解剂,可诱导抗动脉粥样硬化的单核细胞/巨噬细胞表型。